Organic growth of net sales
Organic growth of net sales shows the development of net sales for the operating segments Products & Care and Logistics & IT excluding the effects of acquisitions, new license agreements, openings and closures of pharmacies (effect of net expansion). It provides a “like-for-like” comparison with previous periods. In the business area Retail (B2C), organic growth of net sales is calculated only including points of sales with a full year period comparison. In the business area Professionals (B2B), organic growth of net sales is calculated only including existing business activities with a full year period comparison. In order to show the impact of mandatory price reductions of medications reimbursed by health insurers on net sales transparently, organic growth of net sales is also disclosed without the effect of mandatory price reductions.
Organic growth of net sales first half of 2023
|
in thousand CHF |
Retail (B2C) |
Professionals (B2B) |
Products & Care 1) |
Wholesale |
Logistics & IT Services |
Logistics & IT 1) |
|
Net sales |
679,086 |
128,627 |
804,364 |
1,457,284 |
70,418 |
1,518,491 |
|
Change to previous period |
2.1% |
17.6% |
4.2% |
5.6% |
10.4% |
5.8% |
|
|
|
|
|
|
|
|
|
Effect of net expansion |
3,394 2) |
7,208 3) |
10,602 |
– |
760 3) |
760 |
|
In % of net sales of previous period |
0.5% |
6.6% |
1.4% |
0.0% |
1.2% |
0.1% |
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion |
675,691 |
121,419 |
793,762 |
1,457,284 |
69,658 |
1,517,731 |
|
Organic growth of net sales |
1.6% |
11.0% |
2.8% |
5.6% |
9.2% |
5.7% |
|
|
|
|
|
|
|
|
|
Mandatory price reductions 4) |
9,092 |
|
|
26,589 |
|
|
|
In % of net sales of previous period |
1.4% |
|
|
1.9% |
|
|
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion and mandatory price reductions |
684,783 |
|
|
1,483,873 |
|
|
|
Organic growth of net sales excluding price reductions |
3.0% |
|
|
7.5% |
|
|
1) Including eliminations of intercompany net sales
2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)
3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)
4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period
Organic growth of net sales first half of 2023 Products & Care
|
in thousand CHF |
Local Pharmacies |
Pharmacies at Home |
Retail (B2C) 1) |
Products & Brands |
Services for Professionals |
Professionals (B2B) 1) |
|
Net sales |
640,151 |
39,060 |
679,086 |
89,998 |
38,623 |
128,627 |
|
Change to previous period |
1.9% |
4.6% |
2.1% |
19.8% |
12.8% |
17.6% |
|
|
|
|
|
|
|
|
|
Effect of net expansion |
2,525 2) |
869 2) |
3,394 2) |
6,044 3) |
1,164 3) |
7,208 3) |
|
In % of net sales of previous period |
0.4% |
2.3% |
0.5% |
8.0% |
3.4% |
6.6% |
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion |
637,626 |
38,191 |
675,691 |
83,954 |
37,460 |
121,419 |
|
Organic growth of net sales |
1.5% |
2.3% |
1.6% |
11.8% |
9.4% |
11.0% |
|
|
|
|
|
|
|
|
|
Mandatory price reductions 4) |
9,092 |
– |
9,092 |
|
|
|
|
In % of net sales of previous period |
1.4% |
0.0% |
1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion and mandatory price reductions |
646,718 |
38,191 |
684,783 |
|
|
|
|
Organic growth of net sales excluding price reductions |
2.9% |
2.3% |
3.0% |
|
|
|
1) Including eliminations of intercompany net sales
2) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)
3) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)
4) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period
Organic growth of net sales first half of 2022
|
in thousand CHF |
Retail (B2C) 1) |
Professionals (B2B) |
Products & Care 1) 2) |
Wholesale |
Logistics & IT Services |
Logistics & IT 2) |
|
Net sales |
665,192 |
109,341 |
771,689 |
1,379,426 |
63,794 |
1,434,631 |
|
Change to previous period 3) |
2.5% |
23.5% |
5.2% |
3.8% |
26.2% |
4.1% |
|
|
|
|
|
|
|
|
|
Effect of net expansion |
6,172 4) |
13,467 5) |
19,639 |
– |
– |
– |
|
In % of net sales of previous period |
1.0% |
15.2% |
2.7% |
0.0% |
0.0% |
0.0% |
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion |
659,020 |
95,874 |
752,050 |
1,379,426 |
63,794 |
1,434,631 |
|
Organic growth of net sales 3) |
1.5% |
8.3% |
2.5% |
3.8% |
26.2% |
4.1% |
|
|
|
|
|
|
|
|
|
Mandatory price reductions 6) |
7,262 |
|
|
26,387 |
|
|
|
In % of net sales of previous period |
1.1% |
|
|
2.0% |
|
|
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion and mandatory price reductions |
666,282 |
|
|
1,405,813 |
|
|
|
Organic growth of net sales excluding price reductions 3) |
2.6% |
|
|
5.8% |
|
|
1) Figures restated (refer to note 4 of the Consolidated interim financial statements)
2) Including eliminations of intercompany net sales
3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 1.8% lower for Retail (B2C), 1.6% lower for Products & Care and 0.7% higher for Wholesale and Logistics & IT
4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)
5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)
6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period
Organic growth of net sales first half of 2022 Products & Care
|
in thousand CHF |
Local Pharmacies |
Pharmacies at Home 1) |
Retail (B2C) 1) 2) |
Products & Brands |
Services for Professionals |
Professionals (B2B) 2) |
|
Net sales |
627,947 |
37,349 |
665,192 |
75,097 |
34,244 |
109,341 |
|
Change to previous period 3) |
1.8% |
15.9% |
2.5% |
26.0% |
18.3% |
23.5% |
|
|
|
|
|
|
|
|
|
Effect of net expansion |
6,172 4) |
- 4) |
6,172 4) |
7,721 5) |
5,745 5) |
13,467 5) |
|
In % of net sales of previous period |
1.0% |
0.0% |
1.0% |
13.0% |
19.9% |
15.2% |
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion |
621,774 |
37,349 |
659,020 |
67,375 |
28,499 |
95,874 |
|
Organic growth of net sales 3) |
0.8% |
15.9% |
1.5% |
13.0% |
–1.6% |
8.3% |
|
|
|
|
|
|
|
|
|
Mandatory price reductions 6) |
7,262 |
– |
7,262 |
|
|
|
|
In % of net sales of previous period |
1.2% |
0.0% |
1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
Net sales excluding effect of net expansion and mandatory price reductions |
629,036 |
37,349 |
666,282 |
|
|
|
|
Organic growth of net sales excluding price reductions 3) |
2.0% |
15.9% |
2.6% |
|
|
|
1) Figures restated (refer to note 4 of the Consolidated interim financial statements)
2) Including eliminations of intercompany net sales
3) Growth rate includes minor change in segment reporting structure: adjusted growth rate on a comparable basis would be 26.5% lower for Pharmacies at Home and 1.8% lower for Retail (B2C)
4) The effect of net expansion is calculated only including point of sales without a full year period comparison (acquisitions, openings and closure of pharmacies)
5) The effect of net expansion is calculated only including business activities without a full year period comparison (acquisitions and new license agreements)
6) Mandatory price reductions of medications reimbursed by health insurers of the specialities list (SL/LS) released by the Federal Office of Public Health (FOPH), calculated based on volumes of previous period